A subset of people with autism have genetic and biochemical abnormalities in a sleep-related enzyme, according to research presented Friday at a satellite conference of the Society for Neuroscience annual meeting in Washington, D.C.

Most neuroscientists who study autism focus on genes, pathways and mouse models, and rarely think about the day-to-day experience of people with the disorder, contends developmental psychologist Ami Klin.

A panel of heavyweights from pharmaceutical companies and funding organizations painted a pessimistic picture for the future of autism drugs.

We’re headed to Washington, D.C. for the Society for Neuroscience annual meeting, and hope to make your lives a little bit easier by reporting on what matters to you.

We’re headed to Washington, D.C. for the Society for Neuroscience annual meeting, and hope to make your lives a little bit easier by reporting on what matters to you.

Knowledge of autism in China is spotty, according to a large survey published last month.

Two studies published in the past month highlight the challenges in balancing the accuracy of autism diagnosis with cost-effectiveness and speed.

Over the past 30 years, autism research pioneer Fred Volkmar says he has learned that researchers should be humble when assigning meaning to autism behavior, and seek to translate their findings into useful applications.  

A large, centralized bank of brain tissue from young people could greatly accelerate autism research. Thanks to a growing interest from nonprofit organizations, the idea is finally gaining momentum.

In a study of people missing an autism-linked region on chromosome 22, researchers have found that the larger the deletion, the more likely the individual is to have severe symptoms, from motor and speech delays to a large head and fleshy hands.